• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

氨基葡萄糖修饰多柔比星靶向性研究

李斯文, 田俊梅, 金靖, 杜长丽, 赵娟, 顾月清

李斯文, 田俊梅, 金靖, 杜长丽, 赵娟, 顾月清. 氨基葡萄糖修饰多柔比星靶向性研究[J]. 中国药科大学学报, 2012, 43(3): 266-270.
引用本文: 李斯文, 田俊梅, 金靖, 杜长丽, 赵娟, 顾月清. 氨基葡萄糖修饰多柔比星靶向性研究[J]. 中国药科大学学报, 2012, 43(3): 266-270.
LI Si-wen, TIAN Jun-mei, JIN Jing, DU Chang-li, ZHAO Juan, GU Yue-qing. Targeted biodistribution of aminoglucose-modified doxorubicin[J]. Journal of China Pharmaceutical University, 2012, 43(3): 266-270.
Citation: LI Si-wen, TIAN Jun-mei, JIN Jing, DU Chang-li, ZHAO Juan, GU Yue-qing. Targeted biodistribution of aminoglucose-modified doxorubicin[J]. Journal of China Pharmaceutical University, 2012, 43(3): 266-270.

氨基葡萄糖修饰多柔比星靶向性研究

Targeted biodistribution of aminoglucose-modified doxorubicin

  • 摘要: 为了提高多柔比星(Dox)体内靶向性,降低毒副作用,将2-脱氧-氨基葡萄糖(AG)对多柔比星进行靶向配体修饰,形成一种全新抗肿瘤药物。对产物进行1H NMR、MS表征,运用近红外成像技术对产物靶向性进行研究,并通过MTT法比较产物与多柔比星对MCF-7细胞和U87MG细胞的药效作用。研究表明,与多柔比星相比,修饰过的产物靶向性和药效作用都有很大提高,具有很好的应用前景。
    Abstract: In order to improve in vivotargeting of doxorubicin (Dox) and reduce its toxicity,the targeting ligand 2-deoxy-aminoglucose (AG) was used to modify doxorubicin to form a new anti-tumor drug.The products were charactered by 1H NMR and MS,and the targeting was investigated by near-infrared imaging.Compared with Dox,the product treating MCF-7 and U87MG cells showed higher antitumor activity in vitro by MTT assay.In conclusion,the modified products effectively enhanced the targeting and pharmacodynamics in contrast with Dox,and it would be a potential therapeutic drug for cancer.
计量
  • 文章访问数:  1653
  • HTML全文浏览量:  0
  • PDF下载量:  1953
  • 被引次数: 0
出版历程
  • 刊出日期:  2012-06-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭